Thermo Fisher Scientific Inc. (NYSE: TMO) announced a strategic partnership between its PPD clinical research business and Datavant Inc., the US-based health data connectivity platform, to integrate and analyze real-world data (RWD) across clinical trial operations. The collaboration will enhance randomized trials with RWD enrichment, leverage PPD CorEvitas Clinical Registries, and optimize PPD Evidera solutions through Datavant’s privacy-preserving tokenization technology.
Forward‑Looking Statements This brief contains forward‑looking statements regarding Thermo Fisher PPD and Datavant partnership execution, RWD integration in clinical trials, and real-world evidence regulatory acceptance. Actual results may differ due to data privacy regulation changes, healthcare system interoperability challenges, and competitive responses from IQVIA and other CROs.-Fineline Info & Tech
Insight, China's Pharmaceutical Industry Fineline Info & Tech is a comprehensive global pharmaceutical database that spans the entire product lifecycle. Its mission is to equip professionals and executives across all sectors of the life sciences industry with a standardized data language, offering a holistic view of the Chinese pharmaceutical competitive landscape. Flcube.com furnishes critical data essential for informed decision-making, drawing on global industry news, policy insights, competitive intelligence, and advanced analytical tools.
